Glycogen Synthase Kinase-3β Inhibition Links Mitochondrial Dysfunction, Extracellular Matrix Remodelling and Terminal...

Area of Science:

• Biochemistry
• Cell Biology
• Osteoarthritis Pathogenesis

Background:

• Glycogen Synthase Kinase 3 beta (GSK3β) inhibition is implicated in cartilage degradation.
• The specific effects of direct GSK3β inhibition and its role in mitochondrial pathology within osteoarthritis (OA) remain unclear.

Purpose of the Study:

• To investigate the molecular mechanisms of GSK3β inactivation on human articular chondrocytes.
• To explore the impact of GSK3β inhibition on mitochondrial function and endochondral ossification in OA.

Main Methods:

• Utilized 3-D (micromass) cultures of human articular chondrocytes.
• Applied GSK3β inactivating stimuli at different time points (seeding vs. maturation) to assess short-term and long-term effects.
• Employed pharmacological and silencing strategies for molecular dissection.

Main Results:

• GSK3β inhibition significantly increased mitochondrial oxidative stress and damage.
• Observed enhanced endochondral ossification, indicated by Runx-2 and β-catenin nuclear translocation, calcium deposition, and cell death.
• Demonstrated enhanced extracellular matrix remodeling via increased collagenolytic activity, despite unchanged MMP-1 and reduced MMP-13 expression.
• Identified that GSK3β inhibition affects collagenolytic activity through reduced TIMP-3 and increased MMP-10 and MMP-14.

Conclusions:

• GSK3β inhibition promotes terminal differentiation and cartilage degradation through coordinated effects on the extracellular matrix.
• GSK3β activity is crucial for maintaining articular cartilage homeostasis.